Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Evaluating the impact of PBM wavelengths on CTGF-driven tenogenic differentiation of ADMSCs through multi-level analyses.

Albert A., Abrahamse H., Crous A.

Laboratory Study on Tendon Injury, published in Sci Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Sci Rep (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42409877
DOI
10.1038/s41598-026-60769-3

Abstract (original English)

Evaluating the Impact of PBM Wavelengths on CTGF-Driven Tenogenic Differentiation of ADMSCs Through Multi-Level Analyses" studied the effects of photobiomodulation (PBM) on the tenogenic differentiation of adipose-derived mesenchymal stem cells (ADMSCs) stimulated with connective tissue growth factor (CTGF) using a range of wavelengths (525 nm, 825 nm, and their combination) and fluences (5 and 10 J/cm²). Gene expression (qPCR for COL1A1, COL3A1, TNMD, TNC, BGN, and SMAD3), morphological alterations (Giemsa staining), metabolic activity (ATP test), and cytotoxicity (LDH release) were all evaluated using a multi-level experimental design. On Day 5, ATP production was significantly enhanced without cytotoxicity by using dual-wavelength PBM at 5 J/cm². On the other hand, metabolic activity was decreased but membrane integrity was preserved at a higher fluence of 10 J/cm². By Day 10, the spindle-shaped morphology and cellular alignment were more apparent in Giemsa-stained cells that had been exposed to dual-wavelength PBM. A synergistic impact in promoting tendon-specific lineage commitment was shown by gene expression analysis, which showed substantial elevation of critical tenogenic markers under dual-wavelength PBM at 5 J/cm². Taken together, these results show that PBM works best when the wavelength and dosage are optimized, and they provide credence to the idea that PBM might

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research